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There is no specific protein antigen that has been isolated 
from mycobacterium leprae. This is a significant problem because of 
the difficulties in diagnosing and treatment of the disease. 
The objective of this study was to isolate, identify and purify 
a specific M. leprae antigen with a view to recognizing its ability 
as a specific skin test antigen that could assist in diagnosing the 
leprosy infection in very early clinical stages both in patients 
and their contacts. 
Isoelectric and chromatofocusing techniques were employed to 
evaluate the protein antigens of Mycobacterium leprae and other 
clinically relevant mycobacteria. Following the isoelectricfocusing 
separation, which permitted recognition of differences between the 
protein profiles of M. leprae and other mycobacteria, chromatofocusing 
was used to obtain individual protein fractions from each of the 
species studied. The protein fractions from (untreated) M. leprae 
and (treated) autoclaved M. leprae were then used to evaluate their 
immunologie capabilities both in guinea pigs and mice. Guinea pigs 
sensitized either with homologous and heterologous mycobacteria or 
with the fractions derived from (treated) autoclaved M. leprae were 
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skin tested with the various fractions. There was at least one 
fraction (B) from untreated NU leprae that showed reactions only in 
M. leprae sensitized animals. This specificity was also confirmed 
through immuno-analysis (ELISA). 
Subsequently, BALB/c mice were injected with the various fractions 
in graded doses via the left hind footpad to determine the sensitizing 
abilities of the fractions. Data obtained in these studies indicate 
that the protein antigens possess the ability to elicit delayed 
hypersensitivity as well as to induce such sensitivity, both the 
specific and crossreactive nature. 
This in vivo demonstration of delayed hypersensitivity was also 
confirmed through lymphocyte transformation studies. Sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE) analysis has 
shown that fraction (B) contains a single antigen. A suggestion 
has been made that this single protein could be a target antigen for 
early diagnosis of leprosy, specifically in contacts of leprosy pati¬ 
ents. It could also assist in detecting a latent infection. Addi¬ 
tional studies, using different parameters, should lead to further 
confirmation of its specificity. It has also been suggested that 
such leprae - specific protein antigens could play an important 
role in the immune response of leprosy patients. They could also 
have a significant impact as possible immuno-protective agents, 
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CHAPTER I 
INTRODUCTION 
Leprosy is a disease as ancient as civilization itself. It is known 
to have been endemic in ancient Egpyt, India, and China. Historically, 
leprosy has always had a stigma attached with it. This crippling disease 
robs an individual of his livelihood, with society labelling those 
affected as outcasts even in the present era. 
Leprosy has been mentioned in a record (1350 B.C.) during the reign 
of Rameses II. It reports the disease among slaves from the Sudan 
and Dafur to the South of Egypt. The retreat of Pompey's army from Syria 
in 62 B.C. was followed by the spread of leprosy throughout Europe until 
the fifteenth century when a noticeable decline occurred, and by the 
seventeenth century it had become rare. This decline is attributed to 
rigid regulations for the segregation of those afflicted (Feeny, 1964). 
In the U.S. and Canada, the original cases can be traced to French, 
Spanish, Scandinavian, and Chinese origins. In South America, it is 
believed to have been imported by slaves. The African slave trade, most 
of which came from intensely leprotic areas of Africa, was no doubt a 
vehicle for spread of the disease to the Western Hemisphere. 
Leprosy is a chronic, communicable disease that is mainly confined 
to humans. The disease is virtually a spectrum of abnormal immune 
responses which presents, on the one hand, a very strong expression of 
cell-mediated immunity and, on the other, almost total depression of the 
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same. This depression of CMI, however, seems not to affect the ability 
of patients in the latter group to retain a high level of humoral immunity. 
At times this ability to produce circulating antibodies is higher than 
that observed in the former group or in normal healthy individuals. 
Transmission of leprosy has been known to occur mainly through the 
skin. Once the bacilli (M. leprae) gain entry into the host through this 
portal, they migrate in substantially large numbers to various areas of 
the body, but multiply primarily in the skin, peripheral nerves, upper 
respiratory tract, and the reticuloendothelial system. The organisms 
have a specific predilection for areas of the body with relatively cool 
temperatures. The incubation period is between 3 to 10 years or longer. 
The clinical spectrum varies with the effectiveness of the host's 
immune mechanisms. This factor has been considered in the latest classi¬ 
fication of the disease by Ridley and Jopling (1966), and further extended 
by Ridley and- Waters (1969). The classification was based on a corre¬ 
lation of the clinical features and histological patterns exhibited by 
skin biopsies derived from patients in various stages of infection. 
Considerable efforts have been made towards finding specific antigens 
of mycobacteria that possess the ability to provoke delayed skin reactions 
in hosts sensitized or infected with a given organism. Studies of delayed 
type skin reactivity in animals sensitized with various mycobacteria, 
cell walls, old tuberculin, PPD, and other protein polypeptide fractions 
from mycobacterial cells have been reported (Baer and Chaparas, 1966; 
Daniel and Hinz 1974; Larson et al 1968). These studies were directed 
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primarily towards an evaluation of skin-reactivity of fractions derived 
from BCG and other mycobacteria. However, efforts to isolate specific 
antigens of M. leprae have been limited to phenolic glycolipids (Brennan, 
1980). 
The objective of these studies was to use the isoelectricfocusing 
method for the identification of the protein antigens of M. leprae and 
several other clinically relevant mycobacteria. The chromatofocusing 
separation technique, was used to separate various fractions from M. 
leprae sonicates. These were tested for the following parameters: 
1) The ability to induce delayed-type hypersensitivity in BALB/c 
mice as determined by footpad swelling and by lymphocyte 
transformation. 
2) The ability to elicit both specific and non-specific delayed- 
type hypersensitivity responses in guinea pigs sensitized with 
various mycobacterial strains including M. leprae as determined 
by skin test using the potential antigen. 
3) The ability to bind specifically to antibody in sera from 
immunized animals. 
CHAPTER II 
REVIEW OF LITERATURE 
Clinical Spectrum of Leprosy 
Ridley and Jopling (1966) have provided a diagnostic classification 
that forms the basis of many recent investigations of the immunology of 
leprosy. The bipolar concept of leprosy has been accepted for many years 
(Arnold, 1974). This concept has been expanded by Ridley and Jopling 
(1966) to a five-level system based on the consequence of host responses 
to the antigens of M. leprae. To the traditional bipolar system, viz., 
the tuberculoid (TT) and the lepromatous (LL), they added an intermediate 
stage, borderline (BB), and two other categories to fit within these 
groups, viz., the borderline tuberculoid (BT), an intermediate between 
TT and BB, and the borderline lepromatous (BL), and an intermediate bet¬ 
ween BB and LL. A complete clinical spectrum of the disease is presented 
below: 
Ridley-Jopling Classification of Leprosy 
Leprosy  
Polar 1 Polar 2 
Tuberculoid (TT)  > Intermediate  > Lepromatous (LL) 
Borderline —> Borderline —> Borderline  > Indeterminate 
tuberculoid lepromatous lepromatous 




Owing to the inability to culture M. leprae, it has not been possible 
to obtain a specific antigenic preparation for use as a skin test antigen. 
The only available materials for such a test are the standard lepromin 
preparation and the Dharmendra antigen, both having their specific place 
in the evaluation of the allergic response to M. leprae. The standard 
lepromin is a crude preparation which is derived from autoclaved, pooled 
lepromas and contains dead organisms in addition to human tissue com¬ 
ponents (Rees, 1964). On the other hand, the Dharmendra antigen is a 
more purified suspension of dead bacilli with very little tissue com¬ 
ponents, prepared by extraction with chloroform and ether (Rees, 1964). 
Although it is recognized that a purified suspension would be the most 
suitable material, the crude lepromin preparation is commonly used to 
elicit skin reactivity. This preparation is known to give more consist¬ 
ent results and stronger, more interpretable, reactions (Rees, 1964). 
In lepromatous leprosy, lepromin sensitivity is characteristically 
absent, whereas it is very strongly exhibited by patients with tuberculoid 
leprosy. The skin reaction to lepromin is basically biphasic, with a 
typical delayed hypersensitivity reaction, known as the Fernandez re¬ 
action, occurring between 48 to 72 hr (Rees, 1964). This reaction is 
expressed as an area of erythema and induration which usually ulcerates 
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in patients showing a strong reaction. It is commonly known as the early 
reaction. The second phase of the reaction is the late reaction, known 
as the Mitsuda reaction, which appears within 3 to 5 weeks post skin test 
and presents itself as a nodule at the site of injection (Rees, 1964). 
In patients who exhibit a strong reaction, the nodule may undergo necrosis 
and abscess formation. The Dharmendra antigen usually will elicit the 
early reaction, whereas the crude lepromin gives a strong late reaction. 
It is generally considered that both the early and the late reactions are 
specific for the antigens of M. leprae and are usually correlated in any 
one individual (Rees, 1964). The Mitsuda (late) reaction is considered 
to be a dual reaction, one being to the contaminating tissue components 
and the other to the delayed release of antigens from the intact bacilli. 
The intradermal injection of the integral lepromin could also be acting 
as an antigenic stimulus. 
Leprosy patients in the TT spectrum usually give a very strongly 
positive lepromin reaction, whereas those in the BB through LL stages are 
lepromin negative. Those in the BT stage may be either positive or 
negative, depending on which polar aspect they lean to. However, in most 
such cases, the lepromin positivity is of a low order of magnitude. 
Lepromin positivity does not necessarily indicate any previous 
contact with M. leprae or other mycobacteria (Shepard and Saitz, 1967). 
Waters et aj_. (1971) screened a group of normal healthy individuals who 
had never been in a leprosy endemic area, nor had they received BCG 
vaccination. Nearly 38% of this population exhibited a positive Mitsuda 
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reaction at 3 weeks, but did not show a delayed hypersensitivity reaction 
at 72 hr. This suggests that sensitization may occur from lepromin itself. 
Gunito et_ al_. (1955) found that the responsiveness to lepromin, especially 
to late reaction, increased with age. This situation was found not only 
in household contacts of lepromatous and nonlepromatous cases, but also 
in households where there was no case of leprosy. In a nonendemic area, 
Roteberg et_ aj_. (1950) reported both the Fernandez as well as Mitsuda 
reaction among healthy controls. 
The lepromin reaction, therefore, cannot be used to indicate either 
an infection with or exposure to the leprosy bacillus. It is very 
important however, in the assessment of host immune response in an 
already established disease state, to recognize that a patient favorable 
response to the Mitsuda reaction indicates a very strong cell-mediated 
immune response to M. leprae (Rees, 1964). 
Serology of Leprosy 
Immune response to an infection often involves multiple processes 
that indicate the outcome of the infection. Lymphocytes, phagocytic 
cells, the vascular system, antibody, complement, and other components of 
the host system are known to have significant interactions. In order to 
gain insight into the host's immune mechanisms, one must study most, if 
not all, facets of this complex network. In leprosy, most of the above 
systems have been studied extensively in the past few years, and an effort 
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has been made to elucidate the mechanisms of these systems as related to 
the host-parasite interactions that influence the disease process. 
Antibody Response in M. Leprae Infection 
This area has been the subject of investigations by various workers 
for the past several years (Myrvang et jil_., 1973; Navalkar et jil_., 1964, 
1965, 1973; Ulrich et al_., 1969; Abe, 1970; and Axelson et_ aj_., 1974). 
In each of these studies, anti mycobacterial antibodies have been demon¬ 
strated with high frequency in lepromatous patients and of a low order in 
tuberculoid cases. Navalkar et aj_. (1964 and 1965) first demonstrated 
the presence of antibodies to two serologically distinct antigens in sera 
from leprosy patients in various stages of infection. These antibodies 
were detected most frequently in sera from lepromatous cases, less fre¬ 
quently in sera from the borderline group, and were least common in 
sera from tuberculoid patients. The amount of antibody to mycobacterial 
antigens appeared to be directly related to the bacillary load of the 
patients. Rees et al_. (1965) and Navalkar (1973) have shown a fall 
in the antibody titer as the bacillary load was eliminated through effec¬ 
tive chemotherapy. Subsequent studies by Ulrich et_ al_. (1969), Abe 
(1970), Myrvang et al_. (1973), and Axelson et £]_. (1974) have confirmed 
the presence and distribution of antimycobacterial antibodies employing 
different techniques. 
Navalkar (1973) postulated that the antigens responsible for the 
induction of the two antibodies must form a part of the antigenic 
mosaic of leprosy bacillus, which was later substantiated by antigenic 
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analysis of leprae derived from human lepromata (Navalkar, 1971). 
It appears that lepromatous patients may respond to a given immunogen 
at a substantially higher level of antibody production than either 
tuberculoid patients or normal individuals. Buck and Hasenclever (1963) 
demonstrated serum agglutinins to Candida albicans in leprosy patients. 
The lepromatous patients produced a significantly higher titer than 
tuberculoid patients or normal individuals. Sheagren et_ jil_. (1969) have 
shown that leprosy patients in all stages of infection, when immunized 
with Salmonella typhi antigen, exhibited the same amount of hemagglutinins 
as normal controls, an observation confirmed by Jha et_ al_. (1971), which 
appears to be in direct contradiction to the observations of others. It 
is likely, however, that the high incidence of antibodies to other 
immunogens in lepromatous patients is an anamnestic rather than a primary 
response in some of these patients. 
Although the humoral antibody response appears to vary with the 
clinical spectrum, the ability of leprosy patients to respond to extrinsic 
antigens appears to remain intact, no matter what stages of infection 
they are in. This situation contrasts with what is known about their 
cel1-mediated immunity. 
Cel 1-Mediated Immunity in M. leprae Infection 
When one considers this aspect of leprosy infection, one has to deal 
with the ability of the patient to respond not only to the antigens of the 
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causative organism, but also to other antigens. Cel 1-mediated immunity 
against the antigens of leprae permits the determination of the host 
resistance to infection, clinically established disease when infection is 
induced, and reversal-type reactions. Investigations of immune response 
to leprosy infection have provided direct evidence for these concepts 
(Myravang et_ al_., 1973; Bullock et a]_., 1972 ; Jacobson et aj_., 1974; 
Godai et^ a_k, 1973; Samuel et aj_., 1973 and Barnetson et_ ^1_., 1976). 
Godai et al_. (1973), using the technique of lepromin-induced lympho¬ 
cyte transformation, found that the lymphocytes from unexposed individuals 
showed no responsiveness to the antigen. On the other hand, lymphocytes 
from individuals exposed for more than 1 year showed a high degree of 
responsiveness (80%). These studies have a direct relationship to the 
presence of subclinical infection in exposed individuals and subsequent 
protection through cell-mediated immunity. Myrvang et_ al_. (1973), 
studied lymphocyte responses of patients in all stages of leprosy in¬ 
fection. There appeared to be a progressive decrease in responsiveness 
as the disease progressed from TT to LL, with hardly any responsivity 
among the LI and LL patients. These studies indicate that a patient's 
clinical status has a direct bearing on the level of his cell-mediated 
immunity. Other investigators (Londono et aj_., 1977; Bullock et_ al., 
1974; Bonomo et^ al_., 1965; Wright, 1973 and Saha and Chakrabarty, 1975) 
have studied lymphocyte response in reversel-type conditions. They were 
able to show an increase in lymphocyte reactivity to lepromin during 
the state of reaction, which decreased on subsidence of the reaction. 
Bullock et_ al. (1972), and Jacobson et^ jil_. (1974), administered transfer 
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factor to lepromatous patients. The patients exhibited a reverse-type 
reaction, thus indicating that such reactions could be a result of changes 
in the cell-mediated response of the patients. 
Several studies have been conducted on the suppression of cel 1 - 
mediated immune response in lepromatous (LL) patients (Rea et^ aj_., 1976; 
Guinto, 1968; Talwar et_ al_., 1972; Convit et al_., 1971; Waldorf et al., 
1966; Bullock, 1968 and 1971; Han et aj_., 1971; Dierks, 1968; Nelson et 
al., 1971; Wong et_ al_., 1971 and Ulrich et 1972). The purpose of 
these studies was to evaluate the generalized depression of the ability 
of patients to mount effective cell-mediated immunity and to establish a 
correlation between nonspecific depression and the onset of lepromatous 
leprosy. Methods such as sensitivity to intrade.rmal skin testing agents 
(Rea et aj_., 1976; Guinto, 1968; Talwar et ail_., 1972; Convit et al., 
1971; Bullock, 1968; Saha and Mittal, 1971 and Turk and Bryceson, 1971), 
antigen and mitogen-induced lymphocyte transformation (Myrvang et al., 
1973; Bullock and Fasal, 1971; Godai et al_., 1971; Hans et 1971; 
Dierks, 1968; Wong et al_., 1971; Mehra et_£l_., 1972; and Ulrich et al., 
1972), allergic sensitization to haptens (Convit et al_., 1971; Bullock, 
1968; Saha and Mittal, 1971 and Turk and Waters, 1969), allograft 
rejection (Hans et al_., 1971 and Job et_ al_., 1976), measurement of 
peripheral blood T-lymphocytes (Dwyer et al_., 1973; Mendes et^ al_., 1974; 
Nath et al_., 1974 and Lim et al_., 1974), and lymphokine production in 
vitro (Talwar et al., 1972 and Katz et £l_., 1971) have been employed. 
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One of the most extensively studied aspects of impairment of CMI in 
leprosy patients is the ability of their lymphocytes to undergo blast- 
formation, either in the presence of homologous or heterologous antigens 
or in the presence of mitogenic agents (Rea et al_., 1976; Talwar et al., 
1972; Bullock and Fasal, 1971; Hans et al., 1971; Dierks and Shepard, 
1968; Nelson et_aK, 1971; Wong et_ ^1_., 1971; and Bjune et al_., 1976). 
The first investigation of this aspect was by Dierks and Shepard (1968) 
in which lymphocyte transformation was determined on the basis of morpho¬ 
logical changes. They showed that lymphocyte transformation to phyto¬ 
hemagglutinin (PHA) was markedly diminished both in lepromatous as well 
as tuberculoid patients. Bullock and Fasal (1971) showed depression of 
transformation as measured by -^-thymidine uptake both to PHA and to 
Streptolysin 0 (SLO). However, the SLO-related depression occurred only 
when the cells from lepromatous patients were cultured in autologous - 
plasma. They further showed that plasma from certain lepromatous patients 
had the ability to depress transformation of lymphocytes derived from 
normal healthy individuals to SLO, although no such effect was demon¬ 
strable when PHA was used. Talwar et £]_. (1972) studied PHA responsive¬ 
ness of leprosy patients, using the uptake of -^-thymidine by transformed 
lymphocytes stimulated with PHA. Hans et al. (1971) studied the ability 
of lymphocytes derived from tuberculoid and lepromatous patients and 
from healthy donors to undergo blast formation in the presence of PHA, 
purified protein derivative (PPD), and leprolin, a soluble extract of M. 
leprae. Their results confirmed the observations of other investigators, 
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viz, that lymphocytes from lepromatous patients have a diminished capacity 
to transform in the presence of PHA, PPD, and leprolin, whereas lymphocytes 
from tuberculoid patients undergo blast formation in response to these 
agents. They further showed that the lepromatous lymphocytes partially 
regained their capacity to transform when the disease became inactive 
due to effective chemotherapy. Bjune et al, (1976) correlated the 
lymphocyte transformation response with inflammation of lesions and 
suggested that the transformation is influenced by the occurrence of 
hypersensitivity reactions as well as the patient's ability to resist 
bacillary multiplication. 
Bacteriology 
Armauer Hansen first discovered Mycobacterium leprae in 1874. This 
was the first time a microorganism had been found to be associated with a 
specific disease. These organisms are acid fast rods, 0.3 - 0.5 by 1.0 - 
8.0 urn, with parallel sides and rounded ends. They stain evenly when a 
special stain such as acid fast stain is used. They possess a thick cell 
wall with a lipid layer, a mycolic acid and antigens common to other 
mycobacteria (Harboe et , 1977; Navalkar, 1971). Leprosy bacilli 
which have been obtained directly from human tissues and concentrated, 
have been demonstrated to have cytochrome oxidase and alkaline phospha¬ 
tase (Chaterjee et aj_., 1956) and a specific O-diphenyloxidase activity 
(Prabhakaran et_ £]_., 1968). The detection of the activity of these 
enzymes is important in the identification of 1eprae (Buchanan and 
Gibbons, 1974). Human skin and nerves are rich in these molecules which 
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could explain, in part, the predilection of the bacilli for these tissues 
(Sansonetti and Lagrange, 1981). 
Research in leprosy has been hindered by the fact that M. leprae has 
not yet been cultured in vitro. Attempts have been made however, employ¬ 
ing various standard culture media, special media supplemented with 
hormones, vitamins, and cellular extracts under a variety of growth 
conditions (Bonicke, 1971). Tissue culture studies, using cells from 
human nerves, were also tried but without any success. A culture of the 
organisms in human macrophages which produced a low yield has been 
reported by Samuel et aj_. (1973). Shepard and Guinto (1965) have shown 
that M. leprae have a generation time of 12.5 days when inoculated in the 
footpads of mice as compared to a generation time in synthetic media of 
20 hours for tuberculosis and 20 minutes for Escherichia coli. 
Experimental Animal Models: 
Advances in the study of leprosy have been hampered because of the 
lack of a synthetic growth medium for the bacilli and the absence of a 
suitable animal model. Shepard (1960) opened the door to significant 
advances in the field by demonstrating multiplication of M, leprae in the 
footpad of mice. This has proven to be a suitable system in the study of 
the host-parasite relationship in leprosy. The mouse model has proven 
its value for the clarification of several important aspects, such as the 
generation time of M. leprae (Levy et_ al_., 1974, 1976), identification of 
the so-called isolates of M. leprae (Skinsnes and Matsuo, 1976), screening 
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of new drugs (Shepard et a]_., 1964, 1967, 1972; Levy and Moon, 1972, and 
Levy and Merigan, 1977), demonstration of drug resistance, and the study 
of the immune response to M. leprae (Navalkar et aj_., 1974, Navalkar and 
Patel, 1977; Patel and Lefford, 1978), and evaluation of possible immuno- 
protective measure (Evans et aj_., 1973; Krahenbuhl et_ al_., 1974; Levy, 
1975 and Shepard 1976). Although the mouse model is often used for such 
evaluations, it has its limitations because the multiplication of M. 
leprae in the footpad is restricted in the immunologically intact mouse 
(Shepard, 1960). Consequently, the demonstration of disseminated experi¬ 
mental infection with M. leprae in the nine-banded armadillo by Kirchheimer 
and Storrs in 1971 was thought to be the answer to experimental investi¬ 
gations. Unfortunately, although these animals have some biological 
features (such as low body temperature and a long life span) that were of 
interest to leprosy investigators, the inability of these animals to 
reproduce in captivity, coupled with high cost of maintenance, have 
prevented extensive experimental use of the armadillo, except as an 
excellent millieu for the growth of the leprosy bacillus. 
In recent years, a number of laboratories have been involved in the 
study of the immune response in mice and rats infected either with M. 
leprae or with lepraemurium (MLM) which causes a disease in rodents 
that is pathologically similar to human lepromatous leprosy. Navalkar 
et al_. (1974), studied the immunoglobulin response employing plaque- 
forming cell (PFC) assays in mice that were infected with M. leprae by 
the footpad route. They showed that an IgM response was a direct result 
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of the host-parasite interaction and that the PFC observed resulted from 
stimulation of antibody-forming cells by antigens of M. leprae. They 
were unable to demonstrate any significant elevation of the IgG response 
in these mice despite subsequent secondary challenge with the leprosy 
bacillus. Navalkar and Patel (1977) extended these studies to evaluate 
the cell-mediated immune response in similarly infected mice. Using 
homologous cell extract as one of the skin-test antigens, they were able 
to demonstrate positive skin reactions in the infected mice at the time 
when the bacillary multiplication was nearing the plateau level. Lympho¬ 
cyte transformation assays showed that there was a production and proli¬ 
feration of antigen-reactive lymphocytes and the elevated lymphocyte 
stimulation occurred simultaneously with the increase in skin reactivity. 
They proposed that the cel 1-mediated immunity, thus exhibited by the M. 
leprae infected mice, was basically a T-cell rather than a B-cel1 response. 
Patel and Lefford (1978) studied the induction of CMI to leprae in 
mice and showed that the cell-medi ated immune response was a result of 
the development of delayed-type hypersensitivity to the antigens of M. 
leprae as well as to PPD and that there was a T-lymphocyte-dependent 
macrophage activation at the site of inoculation. Welch and Levy (1976) 
studied the lymph node lymphocytes of M_j_ leprae infected mice. Their 
data suggested that there might be two subpopulations of T-cells, one 
responsive to whole-cell M. leprae antigens and the other to M. leprae 
cell extract. In these studies they showed that the stimulation of the 
lymphocytes to M. leprae antigens occurred only during the latter stages 
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of multiplication of NL leprae, thus indicating that it is at this time 
that antigen-reactive lymphocytes are produced and that these in turn 
may activate macrophages that become capable of killing and clearing the 
M. leprae. Possible vaccines of the future have been tested in protect¬ 
ion studies (Shepard, 1966, 1976), Protection is manifested as reduced 
levels of multiplication of leprae in vaccinated mice as compared to 
unvaccinated controls. Shepard (1966) has shown that vaccination of 
mice with BCG affords protection agains a subsequent challenge with M. 
leprae. According to Shepard et a]_. (1978), M. leprae does not appear to 
lose any of its immunogenicity when it is heat killed. On the contrary, 
it increases moderately when treated with heat. These observations were 
confirmed through adoptive transfer studies by Graham and Navalkar (1984). 
As helpful as it has proven to be, the mouse model and its restricted 
degree of infection with M. leprae, and evaluation of impaired cell-medi¬ 
ated immunity, has a limited scope. It has not proven to be an avenue for 
the study of the decline of cel 1-mediated immunity like that observed in 
lepromatous leprosy. Numerous researchers have therefore employed 
Mycobacterium lepraemurium (MLM) in the studies of murine leprosy as a 
model to understand the mechanism of such impairment, particularly as 
related to chronic infections like leprosy. An infection of rodents 
with these organisms leads to a disseminated, chronic, granulomatous 
infection of a variety of organs with predilection for the lymphoid 
organs. The progression of M^_ lepraemurium infection results in a 
decline in delayed type hypersensitivity (Navalkar and Patel, 1980; 
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Bullock et_ aj_., 1977 and Poulter and Lefford, 1978). Observations by 
Navalkar and Patel (1980) and Poulter and Lefford (1978) showed that 
delayed hypersensitivity is detectable in primary stages of infection but 
diminishes as the infection spreads systemically. This decay was assoc¬ 
iated with a progressive increase in the number of MLM, not only at the 
site of subcutaneous injection into the footpad, but also in all other 
tissues. They suggest that the level of systemic antigen may be in part 
responsible for the loss of DTH. Closs (1975) and Haugen and Closs 
(1975), in their studies on experimental murine leprosy, stated that CMI 
to MLM could only be detected in a resistant strain of mice and implied 
that genetically susceptible mice are immunologically unresponsive to MLM 
infection. Lefford et_ al_. (1977) were able to demonstrate cell-mediated 
immunity to the murine leprosy bacillus in a mouse strain that is highly 
susceptible to this organism. 
CHAPTER III 
MATERIALS AND METHODS 
Mycobacterial Strains 
The bacterial strains used were: Armadillo-deri ved M^_ Leprae; 
M. Kansasii (TMC 1200); avium (TMC 706); M^ vaccae (TMC 1500); M. 
i ntracellui are (TMC 1403); M^ smegmatis (TMC 1400); fortuitum; M. 
scrofulaceum (TMC 92) and M. lufu (Fig. 1). In addition, several strains 
were obtained from S. Chaparas, Bureau of Biologies, NIH, which had been 
identified by him under the International Working Group on Mycobacterial 
Taxonomy (IWGMT) program. M. leprae cells were kindly supplied by A. 
Dhople, Florida Institute of Technology. 
Preparation of Sonicates of M. leprae and other Mycobacteria 
Suspensions of armadillo-derived M^_ 1eprae were washed three times 
in sterile distilled water (Fig. 2). The final pellet was weighed and 
resuspended in a known amount of sterile distilled water. This suspension 
was then divided into two portions, each portion containing 1.2 mg/ml 
(moist weight) of the bacillary mass. One portion was then subjected to 
autoclaving at 120°C for 15 min to obtain a heat-killed preparation. 
The other mycobacterial strains were first grown on Loweninstein-Jensen 
medium (Fig. 3). An inoculum was then transplanted on Sauton medium and 
the cultures were grown for six weeks at 37°C under static conditions. 
The cells were then harvested under aseptic conditions on a Buchner 
funnel, and processed the same way, except they were not heat-killed. 
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Figure 1. Flow diagram of in vitro grown mycobacterial strains used. 
Shown are the culture and identification. 
M. smeqmatls M. kansasll M. avium M. Intracellulare M. vaccae M. scrofulaceum M. fortultum M. lufu 
TTMC'IWDT “ (TRc W 7TMT7ÜS) “ (THC T403)  (TROW ~ JTWT^n  
Lowelnsteln-Jensen Medium (3-6 Meeks, 37°C) 
Morphologic and Microscopic Tests 
-Colonies 
-Acid Fast Stain 
Sauton's Medium 
(4 weeks, 30°C or 37°C) 
no 
o 
Sub-culture Sauton's Medium 
(4 weeks, 30°C or 37°C) 
Figure 2 Flow diagram of the preparation of sonicates of 
M. leprae. 
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M. LEPRAE CELLS (LYOPHILIZED) 
I 
CELLS RESUSPENDED AT KNOWN WEIGHT IN STERILE DISTILLED WATER 
1 
CELLS DIVIDED INTO TWO PORTIONS 
ONE PORTION WAS AUTOCLAVED 
AT 120°C FOR 15 MIN TO OBTAIN 
HEAT KILLED PREPARATION 
DESIGNATED AS TREATED M. LEPRAE. 
THE OTHER PORTION WAS NOT 
TREATED AND DESIGNATED 
AS UNTREATED M. LEPRAE. 
I 1 
DISRUPTED BY SONICATOR IN 
COLD 5x3 MIN EACH WITH 3 
MIN INTERVAL IN BETWEEN 
I 
SONICATES CENTRIFUGED 
AT 9000 xg 4°C FOR 
20 min 
i 
SUPERNATES DISTRIBUTED IN 
ALIQUOTS AND STORED 
"20°C UNTIL USED 
DISRUPTED BY SONICATOR IN 
COLD 5x3 MIN EACH WITH 3 
MIN INTERVAL IN BETWEEN 
1 
SONICATES CENTRIFUGED 
AT 9000 xg 4°C FOR 
20 min 
1 
SUPERNATES DISTRIBUTED IN 
ALIQUOTS AND STORED 
-20°C UNTIL USED 
Figure 3. Flow diagram of the preparation of sonicates of 




INITIAL GROWTH ON LOWEINSTEIN-JENSEN MEDIUM (3 TO 6 WEEKS) 
I 
TRANSPLANTED INTO A SYNTHETIC MEDIUM (SAUTON) 
I 
INCUBATED AT 30°C OR 37°C FOR 6 TO 8 WEEKS UNDER STATIC CONDITIONS 
I 
SURFACE GROWTH SEPARATED ASCEPTICALLY ON BUCHNER FUNNEL 
I 
CELLS WASHED 3 TIMES IN STERILE SALINE TO REMOVE MEDIA COMPONENTS 
i 
CELLS RESUSPENDED AT KNOWN WEIGHT IN STERILE DISTILLED WATER 
l 
CELLS DISRUPTED USING SONICATOR IN COLD 5x3 MIN EACH WITH 3 MIN INTERVAL 
IN BETWEEN 
I 
SONICATES CENTRIFUGED AT 9000 xg AT 4°C FOR 20 MIN 
I 
SUPERNATE DISTRIBUTED IN ALIQUOTS AND STORED AT “20°C UNTIL USED 
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Each mycobacterial suspension was sonicated (Branson Sonifier cell 
Disruptor 185, Branson Sonic Pqwer Co., Banbury, Conn.) with 80 W effect 
and continous pulsing for 5 min at 4°C. Sonication was repeated three 
times within 3 min after each treatment. At the end of this period the 
disrupted material was smear-stained with acid-fast stain to determine 
the extent of breakage. If the breakage was not at a desired level, the 
cells were resubjected to sonication till maximum cell breakage occurred. 
The sonic extract was then centrifuged at 9,000 xg for 20 min at 4°C. 
The supernate was collected under sterile conditions and distributed in 
known amounts in sterile vials, and stored at ~20°C for future use. 
Protein Determination 
The protein content of these sonicates of M. leprae and other myco¬ 
bacteria was estimated with the Protein-Coomassie blue dye binding 
(Bradford, M. 1976) assay with respect to a bovine serum albumin, cyto¬ 
chrome C. and ovalbumin according to the standard assay instruction by 
(Bradford, 1976). The protein solutions were prepared in 0.15 M NaCl. 
Protein solutions containing 10 ug to 100 ug protein in a volume up to 0.1 
ml were pipetted into 12 x 100 mm test tubes. The volume in the test tube 
was adjusted to 0.1 ml with buffer. We then added 3 ml of the protein 
reagent (Coomassie Brillant Blue G - 250, 100 mg dissolved in 50 ml 95% 
ethanol and added 100 ml 85% (w/v) phosphoric acid all diluted to a final 
volume of 1 liter) to the test tube and the contents mixed by vortexing. 
The absorbance at 595 nm was measured after 1 hr in 3 ml cuvettes against 
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a reagent blank prepared from 0.1 ml of the buffer and 3 ml of protein 
reagent. The micrograms of protein was plotted against the corresponding 
absorbance resulting in a standard curved (Fig. 4). 
Preparation of Antisera 
Antisera were prepared against cell sonicates of M, leprae, M. avium, 
M, smegmatis, M. Kasasii, M. intracellulare, M. fortuitum, M. vaccae and 
M, scrofulaceum. After the collection of a serum sample, white male 
rabbits, weighing 2.0 to 2.5 kg were inoculated with 1 ml of a mixture of 
equal volume of cell sonicates and Freund's incomplete adjuvant sub¬ 
cutaneously (S.C.) in the hind-quarter muscle of the animal with a 21- 
gauge needle. Six such injections were given a week apart for six weeks. 
Three rabbits were used for each preparation. The seventh week after the 
first injection, the animals were bled by a "butterfly" cannula apparatus 
fitted with 18-guage needles, from the central ear artery. This was to 
determine the level of specific antibodies by immunodiffusion and immuno- 
electrophoresis analysis. When satisfactory and identical antibody 
responses to any immunizing preparation was noted after the sixth 
week, the rabbits were exsanguinated by cardiac puncture and sera from 
those rabbits that gave a uniform antibody response were pooled for each 
preparation and distributed in known aliquots for storage at "80°C after 
addition of 15 mM sodium azide. If the antibody titer was low, the 




FREUND'S INCOMPLETE ADJUVANT 
TO HIND-QUARTER OF NZW FEMALE RABBITS 
I 
BOOST (WEEKLY) SUB-CUTANEOUSLY WITH 0.5 ml OF 
CELL SONICATES AND BLEED THROUGH EAR MARGINS 
TO TEST FOR MAXIMUM ANTIBODY PRODUCTION 
EXSANGUINATE AT 6 - 7 WEEKS BY CARDIAC PUNCTURE 
Figure 5 Flow diagram of antisera preparation in rabbits against 
cell sonicates. 
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leprae anti serum, an eight week injection schedule was used to obtain a 
good hyperimmune serum. 
Isoelectric Focusing (IEF) 
Initially, cell sonicates from all the strains were isoelectrically 
focused on Ampholine polyacrylamide gel plates (PAG) in which the total 
concentration of acrylamide was 5% and the concentration of the cross- 
linker was 3% with wide pH range of 3.5 - 9.0, using the LKB Multiphor, 
LKB Electrophoresis Power Supply Model 2197. [LKB Instruments, Inc. 
Rockville, MD]. A recirculating cooling unit was used to maintain the 
temperature at 4°C. The procedure was applied according to instructions 
supplied by LKB Instruments, Inc. The conditions were optimized by 
carrying out a variety of runs with respect to applicatton position, 
amount of samples, and power-supply settings. 
A template supplied with the Ampholine PAG plates was placed on the 
cooling platform over a thin layer of paraffin oil, excluding air bubbles 
for cooling efficency. An ampholine PAG plate was placed on the cooling 
platform over the template. Electrode strips supplied with the Ampholine 
PAG plates, were wetted sufficiently with 1 M 0-phosphoric acid (anolyte) 
and 1 M NaOH (catolyte). (Table 1) The wet electrode strips were placed 
on the gel surface as indicated by the template. About 20 ul aliquots of 
each sonicate were then soaked into rectangular pieces of a suitable 3 mm 
filter paper (Whatman, Paratex from LKB), then placed 5 cm from the 
cathodal end, leaving 5 to 10 mm of gel-free space between them. The 
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Table 1. Electrolytes applied to the electrode strips for use with 
isoelectric focusing on Ampholine PAG plates. 
Ampholine PAG plates Anolyte Catholyte 
pH 3.5 - 9.5 1 M 0-phosphoric acid, 1 M NaOH 
pH 4.0 - 6.5 0.5 M 0-phosphoric acid, 0.1 M beta-alanine, 
0.1 M glutamic acid 
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electrode lid was then placed on the electrolyte strips and the connecting 
cables connected to the power supply. The electrofocusing was carried 
out at a constant current (Table 2) for 30 min, after which the 3 mm pads 
applicators were removed (to prevent absorbed proteins from bleeding 
continuously into the gel which may cause tailing) and the focusing was 
continued for an additional 60 min, giving a total of 90 min for the entire 
run. 
On completion of the run, the electrode strips at the cathodal and 
anodal regions were carefully removed. The gel was then immersed in a 
fixing solution consisting of a mixture of 11.5% trichloroacetic acid 
(TCA) and 3.45% sulfosalicylic acid in distilled water for 1 hr, to 
precipitate proteins and to allow the Ampholines to diffuse out. The 
gel was washed for 10 min in destaining solution (20% ethanol and 8% 
acetic acid) then stained for 30 min with Coomassie Brilliant blue R- 
250 dissolved in a mixture of ethanol, acetic acid and water (v/v 500: 
100:2000). The gel was then destained using the same solution without 
the dye. Destaining was repeated at room temperature with frequent 
changes until destaining was satisfactory (until the protein bands could 
be clearly identified) after which the gel was immersed for 1 hr in a 
preserving solution (10% glycerol in destaining solution). 
Subsequent to the initial screening, PAG plates with a narrow pH 
range 4.0 to 6.5 were used for better separation. Except for different 
buffers and time of run, all other procedures were the same as described 
above. The catholyte buffer was 0.1 M beta-alanine and the anolyte buffer 
Table 2. Power supply settings and focusing time used for isoelectric 
focusing on Ampholine PAG plates. 
Ampholine PAG plates 
Parameters pH 3.5 - 9.5 pH 4.0 - 
Power (W) 12 10 
Max. Limiting Voltage (V) 1200 1400 
Max. Limiting Current (mA) 20 20 
Focusing Time 1.5h 3h 
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was a mixture of 0.1 M glutamic acid and 0.5M ortho-phosphoric acid. The 
time for the run was 180 min. 
The pH gradient was determined by the slicing method. The gel was 
cut into 1 cm sections across the electrodes. These sections were soaked 
in test tubes with deionized water overnight at room temperature. The pH 
was then measured with a combination electrode (Orion Research Lab.). A 
mixture of proteins with known pis in the pH range 3 to 10 and 2 to 6.5 
(isoelectric focusing calibration kit, Pharmacia Fine Chemicals, Piscatway, 
N. J.) was used as standard markers respectively. 
Fractionation of M. leprae Sonicates by Chromatofocusing 
Chromatofocusing (CF) is a modified IEF procedure in which column 
separation is utilized. This technique was described by Sluyterman and 
Wijdens, (1978), in which focusing effects are produced in a pH gradient 
on an ion-exchange column. 
The ion-exchange resin polybuffer exchanger PBE-94 and polybuffer 74 
were obtained from Pharmacia Fine Chemicals, Uppsala, Sweden. The resin 
PBE 94 was packed in a 1.0 by 20 cm column, and equilibrated with 10 
column volumes of this starting buffer (0.025 M Histidine-HCl pH 6.5) at 
room temperature. All buffers were degassed before use. After equili¬ 
bration, 1ml of a given sonicate was applied to the top of the column. 
Prior to loading the column, each sample was first dialyzed against three 
changes of 200 volumes of 0.025 M Histidine-HCl pH 6.5 at 4°C for 48 hr. 
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The first elution was done with 10 ml of the starting buffer. The elution 
was then continued at room temperature with 10 column volumes of PB-74 
which had been diluted to a ratio of 1:10 with distilled water and 
adjusted to pH 3.8 with HC1. The eluates were collected at a volume of 
4.5 ml/tube, and the absorption of each fraction at 595 nm was determined 
using the Bradford technique 1976, and the pH of each eluate. The eluates 
were pooled according to the protein peaks and based on absorption data 
to obtain various fractions. The pooled fractions were first concentrated 
by pervaporations and intermittant dialysis. The concentrated fractions 
were then lyophilized and maintained at 4°C until used. To obtain suffi¬ 
cient quantities of each fraction from M_^_ leprae sonicates, a series of 
such separations was carried out. 
Analysis of Sonicates and Fractions with Enzyme-Linked Immunosorbent Assay 
(ELISA) 
The activity of fractions from untreated and autoclaved leprae 
and sonicates of the two preparations as antigens were tested against the 
following antisera; M^_ leprae, M. kansasii, M. smegmatis; M. vaccae, M. 
avium, BCG, tuberculosis, M. intracellulare, and scrofulaceum. 
Ninety-six well polystyrene microtiter plates were coated with 25 ul of 
phosphate buffered saline (PBS) at pH 7.2 and 25 ul of each fraction, 
and incubated at 37°C overnight. Then, 100 ul of 1% bovine serum albumin 
(BSA) was added to each well and the plate was incubated at 37°C for 2 
hr. The BSA was then decanted, and the wells washed three times with PBS 
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pH 7.2. Then 50 ul of a given antiserum, diluted 1:100 in PBS, was added 
to each well and incubated at 37°C for 2 hr. Each well was again washed 
three times with PBS, pH 7.2, before adding 50 ul of peroxidase-conjugated 
anti-goat diluted serum 1:100 (Cappal Laboratories, Downingtown, PA) and 
incubating at 37°C for 1 hr. Each well was again washed three times with 
PBS, pH 7.2, before adding 100 ul of a substrate dye mixture (0.003% H2O2 
and ABTS) which was allowed to react at room temperature. At the end of 
30 min, the reaction was stopped by the addition of 50 ul of 2N H2SO4 to 
each well. The color development was read visually, and recorded as 
positive-to-negative according to the color intensity and controls. 
Skin Reactivity Studies 
These studies were done in two parts. In both experiments, female 
Hartley-strain guinea pigs were used. Before sensitization, the animals 
were skin-tested with lepromin. In the first series of experiments, 
groups of three animals weighing 300-350 g were sensitized, one group 
each with two 1:1 mixtures of cell sonicate and Freund's incomplete 
adjuvant administered subcutaneously over the sternum, with an interval 
of three weeks between injections. Six weeks after the first injection, 
the animals in each group were skin-tested with 0.1 ml of the respective 
cell sonicates and the five fractions obtained from the M. leprae sonicate 
injected intradermally into freshly shaven flank or belly skin. Normal 
and saline controls were always included in each test. The injection 
sites were examined at 6, 24 and 48 hr for the extent of erythema, edema 
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and induration (measured as increases in skin-fold thickness using 
Schnel ltaster dial gauge calipers). 
In the second series of experiments, the guinea pigs were sensitized 
in a similar manner as in the first series, with fractions obtained from 
(treated) autoclaved M. leprae sonicates and sonicates from untreated M. 
leprae and (treated) autoclaved M^_ leprae. Six weeks after the first 
injection, the animals in each group were skin-tested with the fractions 
from M. leprae and (treated) autoclaved M. leprae and the sonicates of 
both preparations. The skin reactions were measured as described above. 
Footpad Studies 
These studies were done in two parts. Part one consisted of seni- 
tizing-the mice with fractions from untreated leprae and footpad 
tested with the homologous cell sonicate. Part two consisted of sensi¬ 
tizing the mice with fractions from both the untreated and (treated) 
autoclaved M. leprae sonicates. Footpad testing in these animals was done 
with the same fractions. 
In the first study, one hundred female BALB/c mice were used. The 
animals were divided into five groups of twenty per fraction. These were 
then separated into groups of five animals per cage the after admini¬ 
stration of 0.03 ml (40 ug of protein) of each fraction in aqueous state. 
The material was given intradermally in the left hind footpad, in two 
doses, spaced a week apart. Animals in each cage were dye-marked for 
reading of footpad swelling to ensure that the reactions in the same 
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mouse would be read at pre-determined intervals. Four animals were 
kept as controls. 
In each group the five animals per cage were footpad tested at 4,6,8 
and 12 weeks respectively. Animals previously tested were not used 
again. The tests were done using the untreated leprae sonicate as 
testing material. A 0.01 ml aliquot of the sonicate was injected intra- 
dermally in the right hind footpad in the test animals. Sterile saline 
was given in a similar manner to control animals. Footpad swelling was 
measured at 0,24 and 48 hr with a dial gauge caliper (Schnel lataster 
System, Kropein, West Germany) and recorded. A difference of 1 mm in 
measurement between the thickness of the footpad in test animals and 
that of the control animals was considered a positive reaction. The 
selection of two doses for sensitization was based on earlier experiments 
in which animals given two injections were found to react more effectively 
than those given a single injection. 
In the second part of this study, one hundred and thirty-two 
BALB/c female mice were used. These were divided into three groups. 
The two test groups had sixty mice per group. These were further 
divided into twelve animals per fraction, (five each from the two cell 
sonicates). A separate group of twelve animals was maintained as con¬ 
trols. The twelve animals per fraction were further divided into three 
animals per cage after sensitization, with the animals in each cage being 
used for footpad and lymphocyte transformation assays conducted at weeks 
1,3,5 and 7. 
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Each fraction was given in two doses of 0.03 ml per dose per animal 
in the left hind footpad of the animals as described above. Animals in 
each cage were dyemarked as in the earlier studies. One week after the 
second sensitization, the animals were tested for footpad swelling, 
using the same fraction with which the animals were sensitized. This 
material was administered in the right hind footpad and the footpad 
thickness was measured and recorded as mentioned above. 
Lymphocyte Transformation Studies 
72 hr after the footpad testing, the three animals in each group 
were sacrificed by cervical dislocation and their spleens removed 
asceptically. The spleens were placed in a sterile petri dish contain¬ 
ing sterile Hanks' balanced salt solution (HBSS). The sensitized spléno¬ 
cytes were expressed from the tissue with sterile blunt forceps, using 
a nylon gauze to obtain a single cell suspension. Splenocytes from the 
three animals per fraction were pooled, washed and the pellet resuspend¬ 
ed at a concentration of 1 x 10^ viable cells per ml of RPMI 1640 tissue 
culture medium. The medium was supplemented with 100 U of penicillin and 
100 ug of streptomycin per ml, 0.3% glutamine and 10% heat-inactivated 
fetal calf serum (Difco Laboratories, Detroit, Michigan, U.S.A.). Via¬ 
bility of the cells was done using the Trypan Blue dye exclusion test. 
Two hundred microliters of each cell suspension was added per well 
of a 96-well microtiter plate. Triplicate wells were used for each test 
antigen and mitogenic agent. Sterile saline was added to the control 
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wells. Cell cultures, in triplicate, were stimulated by the addition 
of phytohemagglutinin (PHA-Difco Laboratories, Detroit, Michigan, U.S.A), 
to a final concentration of 1 ug/ml, the respective fractions and the 
two cell sonicates at a concentration of 10 ug of protein per ml. The 
plates were incubated at 37°C for 96 hr in a 5% CO2 atmosphere. 
All lymphocyte cultures were pulse-labelled by adding 10 ul (10 
uCi/ml of ^H-Tdr (specific activity: 1.9 Ci/mmol; Schwartzmann) in HBSS 
to each well and the plates were incubated at 37°C for 18 hr. The cells 
were harvested using an automatic cell harvester (Titertak). The filter 
discs were cut and dried overnight in scintillation vials. Five ml of 
scintillation fluid (Toluscint diluted 45:1000 with toluene) were added 
to the vails. All samples were counted in a Beckman LS-150 liquid scintil¬ 
lation counter with a counting error of 4% or less. 
Sodium Dodecyl Sulfate-polyacrylamide Gel Electrophoresis (SDS-PAGE). 
The gel system contained a gradient resolving gel 10-20%, a 3% 
stacking gel, and discontinuous which allowed for stacking and unstacking 
of SDS-protein complexes. 
Gel Casting. Resolving Gel (gradient gel) is formed by mixing equal 
parts of 10% and 20% gel solution (See Appendix) in a gradient mixer. 
The gels are then casted in a Bio-Rad Model 360 mini vertical slab-gel 
casting apparatus. The gel slabs were formed between glass plates mea¬ 
suring 16 by 14 cm with a 0.75 mm plastic spacer. The 10% and 20% gels 
are made by mixing the following solution in the order listed: 
38 
Components 10% 20% 
Resolving gel acrylamide/bi s 4.5 ml 8.8 ml 
Lower gel buffer 4.7 ml 4.5 ml 
Water 9.0 ml 4.3 ml 
TEMED 0.29 ml 0.29 ml 
Ammonium persulfate 0.23 ml 0.17 ml 
Stacking Gel. The stacking gel was made by mixing 3 ml of each of 
the following solutions: Upper gel buffer, stacking gel arcylamide/bi s 
solution, TEMED (1:4 diluted) and Ammonium persulfate (1:8 diluted). 
(See appendix). After the resolving gel had polymerized, an 0.8 mm thick 
sample - spacer comb was inserted. The stacking gel mixture was injected 
with a 22-gauge needle and then allowed to polymerize. After polymeri¬ 
zation the sample-spacer comb was removed. 
Sample Buffer. The sample buffer consisted of the following, 1 ml 
of 0.5 M Tris-HCl, pH 6.8; 0.80 ml glycerol; 1.6 ml of 10% (w/v) SDS; 
4.0 ml distilled water; 0.4 ml 2-beta mercaptoethanol and 0.05% (w/v) 
bromophenol blue. 
Samples and standard molecular weight markers were diluted 1:4 with 
the sample buffer and then heated at 65°C for 15 min in a water bath, 
before applying about 20 ul of each sample into the slab wells. The two 
slab gels were then placed in the electrophoretic chamber. About 200 ml 
of upper reservoir buffer (See Appendix) were added into the upper buffer 
chamber and also about 200 ml of lower gel buffer (See Appendix) were 
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added into the lower buffer chamber. The lid was then put in place and 
the terminals connected to a constant power supply (LKB Model 2109). 
SDS-protein complexes were stacked into the stacking gel at 10mA per 
slab. When all the samples had entered the resolving gel, the current 
was then increased to 20 mA per slab, 1400 voltage and a constant power 
of 20W. Electrophoresis was continued until the bromophenol blue dye 
reached the bottom of the resolving gel which was about 4-5 hr. 
Staining Resolved Samples. The gel slabs were removed from the 
glass plates and immersed in 300 ml of a 45% methanol/12% acetic acid 
mixture for 30 min with mild agitation. After removing the methanol/ 
acetic acid mixture, the gels were maintained in about 250 ml of a 10% 
ethanol/5% acetic acid mixture for 10 min. Three such changes were made 
before immersing the gels in about 250 ml of 10% glutaraldehyde for 30 
min. The glutaraldehyde was removed and the gels were washed 3 times for 
30 sec with distilled water, and 3 times for 10 min with distilled water. 
Next, the gels were immersed in about 250 ml of 10 ug/ml DTT for 30 min. 
The DTT was removed and about 300 ml of 0.012M silver nitrate (AgN03) 
solution was poured onto the gel. This was allowed to stay for about 30 
min. The AgNÛ3 solution was removed and the gels were rapidly rinsed two 
times with 300 ml of sodium carbonate/formaldehyde mixture (Na2C03/HCH0) 
and then the protein bands in the gel were allowed to develop in about 
300 ml of this same mixture. This treatment was discontinued when the 
bands could be observed clearly and the gels were then treated with about 
300 ml of 1% acetic acid to stop the reaction. 
CHAPTER IV 
EXPERIMENTAL RESULTS 
Isoelectric Focusing (IEF) 
Separation of proteins by IEF on Ampholine PAG plates revealed 
similarities and differences between the patterns obtained with each 
cell sonicate. Initially, cell sonicates from some of the strains were 
electrofocused on PAG plate at pH 3.5 - 9.0 (Fig. 6). At least 12 
distinct leprae proteins present in the cell sonicate were focused 
in the acidic region between pi 3.8 to 6.0 in the wide range (pH 3.5 - 
9.0 gel) (Fig. 6), and with better resolution in the narrow pH range 
(4.0 - 6.5) (Fig. 7). This better resolution was due to the longer se¬ 
paration distance in the narrower pH range. 
The best position for sample application was approximately at 
the middle of the slab (i.e., 40 nm from the anodal electrode strip). 
Immunoelectrophoresis 
Optimal resolution of immuno-preci pi tin arcs was observed in immuno- 
electrophoresis (IEP) with the following conditions: 1% agarose (medium 
electroendosmosis) barbital buffer pH 7.6, ionic strength 0.05, operated 
at 6 V/cm for 40 to 60 min. The maximum number of precipitin arcs in 
immunodiffusion analysis and IEP was observed after 6 to 7 weeks of 
immunization as shown in Fig. 8 and 9. All rabbits showed consistency 
in antibody production against their respective cell sonicates when 
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tested by immunodifusion. No immunoprecipitin arcs were observed when 
normal rabbit serum was tested against M. leprae antigens. 
Fractionation of M. Leprae by Chromatofocusing 
Figures 10 and 11 give the elution profiles of the two M. leprae 
preparations (untreated M. leprae cell sonicates and autoclaved M. leprae 
cell sonicates). Each strain presented a distinct profile, with respect 
to the number of proteins it contained as well as their quantity. The 
chromatofocusing elution also permitted obtaining individual fractions 
containing the protein antigens, which were used for later studies. 
Analysis of Sonicates and Fractions by Enzyme Linked Immunoasorbent Assay. 
Table 3 gives the result of the ELISA tests done on the fractions to 
determine the specificity and crossreactivity of the antigens contained 
in them. The quantitation is expressed as percent positive for each 
system analysed. As can be seen from these data, fraction A gave posi¬ 
tive reactions with reference systems of M. marinum, M. smegmatis and M. 
leprae - the homologous system. Quantitatively, the reactions with 
marinum and smegmatis were at a level of 5% and with M. leprae, they were 
at a level of 20%. The antigen(s) in fraction C cross-reacted with an 
antigen in M. tuberculosis and M. vaccae. Similar sharing of antigens was 
exhibited by antigens contained in the rest of the fractions. Of parti¬ 
cular significance are the data on the antigen in fraction B, which 
showed strong positive reactions with an antigen in the M. leprae system 
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and borderline positive with an antigen in the M. tuberculosis system. 
Quantitatively, the latter is considered as negative since it was at 
a level less than 2%. None of the fractions derived from autoclaved 
M, leprae showed any such specificity. Both the untreated and auto¬ 
claved M. leprae sonicates showed the presence of crossreacting antigens 
with the different systems tested, except that the autoclaved sonicate 
was rather limited in its reactivity. 
Skin Reactivity Studies 
Table 4 shows the size of the skin reactions observed in guinea pigs 
sensitized with various mycobacteria and skin-tested with the various 
antigens. Each result represents an average of four experiments, with 
three animals per group in each experiment. The control animals exhibited 
no reactions or only weak reactions to all of the skin-testing materials. 
In the test animals, the homologous sonicates elicited strong reactions. 
Of the five fractions from untreated ML leprae used for skin testing, 
most fractions elicited positive reactions in a majority of the animals. 
Of particular interest is the ability of fraction B to elicit skin re¬ 
actions only in animals sensitized with the untreated M. leprae sonicate. 
Apparently, fractions A,C,D, and E, that produced reactions in animals 
sensitized with other mycobacteria, contained more than one antigen. 
Table 5 shows the size of skin reactions in animals sensitized with 
fractions from (treated) autoclaved M. leprae and the two cell sonicates 
(Autoclaved Leprae and untreated leprae) and skin tested with the 
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fractions from autoclaved leprae, fractions from untreated 1 eprae 
and the sonicates from the two preparations (autoclaved leprae and 
untreated leprae). This table shows that a given fraction of auto¬ 
claved elicited stronger reactions in animals sensitized with 
that fraction and weak or no reaction in animals sensitized with other 
fractions. Also, these fractions elicited stronger reactions in animals 
sensitized with the autoclaved M, leprae sonicates, from which they were 
derived, than in animals sensitized with the untreated M. leprae sonicate. 
Fraction A and B derived from untreated M, leprae elicited no reactions 
in the animals sensitized with autoclaved M. leprae fractions. However, 
fraction D and E were able to elicit reactions in these animals especially 
fraction E which showed positive responses in animals from all the groups. 
Of significance here, is the inability of fraction A and B to elicit re¬ 
actions in most animals from any group, except those that were sensitized 
with the untreated leprae. Fraction C was able to elicit a positive 
response in animals sensitized with the autoclaved M. leprae sonicate. 
Footpad Studies 
Table 6 gives the data on part one of these studies. The footpad 
swelling at different intervals in animals sensitized with fractions 
from untreated M. leprae was positive from week 4. This positivity per¬ 
sisted up to twelve weeks, thus indicating that the antigens in these 
fractions also possessed sensitization capabilities. 
Table 7 gives information on the ability of the fractions derived 
from both preparations, not only to sensitize, but also to detect this 
sensitivity. The antigens in each fraction initiated sensitization 
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as early as the first week post-sensitization. However, this sensiti¬ 
vity appeared to decline with time. The fact that the antigens in the 
fractions possess eliciting properties has been confirmed through these 
studies, in addition to the fact that they are also capable of inducing 
delayed skin reactivity. 
Lymphocyte Transformation Studies 
Figures 12 and 13 give the data on lymphocyte transformation studies. 
The results show the average of triplicate cultures for two different 
experiments. The lymphocyte stimulation index was calculated as counts 
per minute obtained in a stimulated culture of lymphocytes from mice in a 
given test group divided by counts per minute obtained in a non-stimulated 
culture of lymphocytes from mice in the same group. 
The result of j_n vitro transformation in the presence of the anti¬ 
genic fractions derived from the two sonicates appear to correlate well 
with results obtained in the skin test studies. The response to phyto¬ 
hemagglutinin, a non-specific T-cell mitogen, in most instances was on 
par with the increase and decline in mitogenic activity of the fractions 
and the two cell sonicates. All stimulating agents induced DNA synthesis 
very early in the experimental protocol. Some exhibiting a higher degree 
of stimulation than others, but in general keeping a consistent profile 
with respect to a steady decline which occurred by about the fifth week 
and persisted till the completion of the experiments in the seventh week. 
Since lymphocyte transformation is a known correlate of delayed hyper¬ 
sensitivity, the results obtained in these studies confirm the ability of 
the antigens in the various fractions to induce sensitization. 
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Sodium Dodecyl Suifate-Polyacrylamide Gel Electrophoresis 
The sonicates and fractions of untreated leprae were analysed 
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a dis¬ 
continuous buffer system in a slab gel electrophoresis using 10-20% 
gradient resolving gels. The molecular weights of the untreated M. leprae 
ranged from about 14,000 to above 94,000 as shown in Figure 14. The SDS- 
PAGE analysis of the untreated M. leprae fractions and the number of pro¬ 
teins each contain is shown in Fig. 15. The single protein band in 
fraction B is located between 45,000 to 66,000. 
Figure 6. Isoelectric focusing of cell sonicates of various 
mycobacteria and untreated M. leprae on a wide 
range Ampholine PAG plate, pH 3.5 - 9.0. Samples from 
left to right: M. intracellulare; M. leprae; M. avium; M. 
leprae; M. kansasi; M. leprae and reference protein mixture 
with known pis. The three M. leprae have 100, 200 and 300 
ug protein/lane respectively. 
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Figure 7. Isoelectric focusing of cell sonicates of various myco¬ 
bacteria on a narrow range Ampholine PAG plate, pH 
4.0-6.5. Samples (from left to right): M. kansasi; .M. 
scrofilaceum; M. avium; M. leprae and reference protein 
mixture with known pis. Note the better resolution in the 





Figure 8. Comparative Immunoelectrophoresis analysis of various 
mycobacteria cell sonicates against rabbit antisera 
at 6 weeks of Immunization. 
1 = M. fortuitum cell sonicate A = M. leprae antisera 
2 = M. leprae ceil sonicate 
3 = BCG cell sonicate 
4 = M. leprae cell sonicate 
B = BCG antisera 
C = M. leprae antisera 

Figure 9. Kinetics of antibody formation (precipitin bands) against 






Number of Major Precipitin Band 
Table 3. ELISA assays of fractions and sonicates of untreated and autoclaved M. leprae 
tested against antisera from various mycobacteria* 





A B C D E I II III IV V CS CS 
M. tuberculosis - ♦ + + + + + + - + + + ♦ 
BCG - - - + + + + - + - + - 
M. avium - - - - - + - - - - + - 
M. Intracellululare - - - - - + - - - - + - 
M. kansasii - - - - + + - + - - + + 
M. scrofulaceum - - - - + ♦ - - - - + + 
M. marinum + - - + - + + + + - - - + + 
M. smegmatis + - - - + + + - - + 
M. vaccae + - + - - + + - ++ ++ + + 
M. leprae 
Tuntreated) 
+ ♦ ++ + + + + ++ + + + + 4-+ + + + ++ 
♦Conversion of signs to percentage: - = < 2%; = < 5%; + = 5 - 20%; ++ = 20 - 40%; +++ * > 40% 
Fractions A to E = from untreated M. leprae; Fractions 1 to 5 => from autoclaved M. leprae 
Table 4. Skin reactivity in guinea pigs sensitized with sonicates front different mycobacteria 
and tested with fractions from untreated M. leprae. 
Size (mm of skin reactions, at 4£ h in animal s sensitized w1 th CS from 
Skin Test Untreated Autoclaved M. kansasli M. avium M. Intracellu- M. vaccae 
Antigens M. leprae M. leprae 1 are 
Untreated 
M. leprae CS 18 x 20N NR ND ND ND ND 
Fraction A 12 x 12 NR 5x5 6x6 NR 6x6 
B 11 x 12N NR NR NR NR NR 
C 16 x 13 N 10 x 11 10 x 10 9 x 10 10 x 10 9 x 10 
D 10 x 11 8x8 NR NR 5x6 NR 
E 9x11 6x5 NR NR 8x8 NR 
Autoclaved M. leprae 
CS 
ND 20 x 2ON ND ND ND ND 
M. kansasli CS ND ND 20 x 2ON ND ND ND 
M. avium CS ND ND ND 23 x 2ON ND ND 
M. Intracellulare CS ND ND ND ND 16 x 18 ND 
M. vaccae CS ND ND ND ND ND 20 x 2ON 
N = necrosis; ND = Not done; NR = No visible reaction 
Table 5. Skin reactivity in guinea pigs sensitized with fractions from autoclaved M. leprae, the two sonicates and 




Size (mm) of skin reactions at 48 h in animals tested with* 






I 20 x 18 - - - - - - - - 9x9 10 x 10 10 x 7 
II - 12 x 12 - - - - - - - 11 x 11 - 12 x 10 
III - - 12 x 10 - - - - 8x8 9 x 10 - 10 x 8 
IV - - - 10 x 8 - - - - 8 x 5 11 x 11 - - 
V - - - 12 x 10 - - - 8x5 12 x 12 - 10 x 10 
Untreated 
M. leprae 8x8 “ “ “ 13 x 13 13 x 13 9 x 10 8 x 10 8 x 9 20 x 20 10 x 8 
Autoclaved 
M. leprae 12 x 10 12 x 10 10 x 8 10 x 8 10 x 7 “ " 12 x 10 10 x 10 10 x 10 10 x 7 20 x 18 
I* - V = Fractions from autoclaved M. leprae; A - E = Fractions from untreated M. leprae 
in 
no 
= No visible reactions or reactions less than 5 mm 
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Table 6. Footpad swelling in BALB/c mice sensitized with fractions 
from untreated M. leprae and tested with untreated M. 
leprae cell sonicate 
Mice sensitized 
with fractions 
Foot pad swelling (mm) at weeks 
4 6 8 12 
A 1.11 1.20 1.30 1.50 
B 1.08 1.15 1.20 1.31 
C 1.08 1.08 1.16 1.32 
D 0.96 1.02 1.10 1.21 
E 1.08 1.08 1.20 1.3 
LHF = Left hind footpad; RHF = Right hind footpad. 
Sensitization was done in the left hind footpad (LHF) 
and testing in right hind footpad (RHF) 
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Table 7. Footpad swelling in BALB/c mice sensitized with a given 




Foot pad swelling (mm) at weeks 
1 3 5 7 
A/A 1.10 1.25 1.0 0.96 
B/B 1.20 1.32 1.15 1.00 
C/C 1.30 1.12 1.12 1.98 
D/D 1.31 1.20 1.0 1.0 
E/E 1.30 1.02 0.96 0.75 
I/I 0.85 0.81 1.30 1.15 
I I/I I 0.75 1.20 0.98 0.82 
11 I/I 11 0.62 0.80 0.62 0.62 
IV/IV 0.68 0.92 0.68 0.52 
v/v 0.98 1.20 0.90 0.52 
*LHF = Left hind footpad; RHF = Right hind footpad. 
Sensitization was done in the left hind footpad (LHF) 
and testing in right hind footpad (RHF) 
Chromatofocusing curve of untreated M. leprae. There are 
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Figure 11. Chromatofocusing curve of autoclaved M, leprae. There 
are five peaks pooled as fraction I,II,III,IV and V. 
We collected 2 ml in each tube. This has a broader peaks 
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Figure 12. Blastogénie responses of lymphocyte cultures derived at 
various intervals from BALB/c mice sensitized with a given 
fraction from untreated M. leprae and cultured in the 
presence of PHA, cell sonicates from untreated M. leprae, 
autoclaved M. leprae and the same fraction. 
PHA (Phytohemagglutinin) = Square 
AL (Autoclaved M. leprae sonicates) = Triangle 
RL (Untreated M. leprae sonicates) = Circle 
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RL = Circle 
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Figure 13. Blastogénie responses of lymphocyte cultures derived at 
various intervals from BALB/c mice sensitized with a 
given fraction from autoclaved M. leprae and cultured 
in the presence of PHA, cell sonicates from untreated 
and autoclaved M. leprae and the same fraction. 
PHA (Phytohemagglutinin) = Square 
AL (Autoclaved M. leprae sonicates) = Triangle 
RL (Untreated M. leprae sonicates) = Circle 
I,II,III,IV and V (Fractions from autoclaved M. 
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Figure 14. SDS-PAGE of untreated M. leprae sonicates. Left lane 
M. leprae sonicate; right lane: molecular weight 
marker. 
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Figure 15. SDS-PAGE of untreated M. leprae sonicates and fractions 
derived from the same sonicate. From left lane to 
right lane: Molecular weight marker, M. leprae sonicate. 




Many investigators have employed chromatographic methods to obtain 
single antigens from mycobacteria, mostly those that grow in vitro (Baer 
and Chapara, 1966, Birnbaum and Affronti, 1969, 1970; Daniel and Hinz, 
1974). However, efforts to obtain such antigens from j_n vivo grown 
mycobacteria, especially M. leprae, have been rather limited (Abe et al., 
1972; Caldwell and Buchanan 1979; Chakrabarty et_ aj_., 1982; Ivanyi et_ 
al., 1983; and K1 aster et_ al_., 1984). Most of these investigators have 
used DEAE-cel lui ose or SDS-PAGE analyses. This is the first report on 
employing isoelectric and chromatofocuslng for such separations. These 
two techniques have the capability to separate protein antigens accord¬ 
ing to their isoelectric point (pi) and thus afford an opportunity to 
recognize the protein profiles of different mycobacteria. 
Antigenic studies of leprae have been in progress for several 
years with success being achieved in obtaining a 1eprae - specific 
phenolic glycolipid antigen that has serological specificity (Brennan 
and Barrow, 1980). Although several investigators have recently defined 
various protein antigens of leprae using enzyme-treatment (Caldwell 
and Buchanan, 1979) and genetic cloning (Clark-Curtiss et_ al_., 1985 and 
Young et al_., 1985), so far attempts to evaluate their biological acti¬ 
vities have remained at a minimum. 
Our efforts have indicated several significant differences in the 
protein antigens of the organisms studied. In particular, the number 
of protein antigens identified by our isolation techniques. 
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Isoelectric focusing of the sonicates from several mycobacteria has 
clearly indicated that all mycobacteria possess protein antigens that are 
acidic in nature. This has been shown repeatedly through the distribution 
of the protein bands between pH 3.5 to 5.5 with all mycobacteria, except 
M. leprae. The protein bands of this organism extend beyond pH. 5.5 to 
6.5. The fact that all mycobacterial protein antigens studied are acidic 
in nature is very significant and has been demonstrated for the first 
time. In addition, the distinctly different antigenic profile of M. 
leprae allows it to be distinguished from other mycobacteria as well as 
other possible acid-fast isolates obtained through in vitro culture of M. 
leprae. 
Chromatofocusing separation allowed further confirmation of the 
differences between the various mycobacteria as related to their protein 
antigens. This is a modified isoelectric focusing technique wherein a 
pH gradient is produced on an ion-exchanger. When such a pH gradient is 
used to elute proteins bound to the ion exchanger, the proteins elute in 
order of their isoelectric point (pi). In addition, focusing effects 
occur resulting in band sharpening, sample concentration and high 
resolution. By employing this method, it has been possible to obtain 
several protein-containing fractions which were subsequently used for 
further evaluations. Both the IEF and CF assays of the sonicates of 
untreated leprae and autoclaved leprae show considerable differences 
in the protein antigens of these two preparations. Several bands pre- 
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sent in untreated leprae were not visible in the autoclaved pre¬ 
paration. It is likely that the bands that were not seen in the auto¬ 
claved leprae were those of heat-labile proteins whereas those that 
were present were of heat-stable proteins. 
In the present studies, we have obtained several antigen-active 
fractions using the chromatofocusing technique. One of which (-fraction 
B-) showed skin-reactivity only in animals sensitized with untreated M. 
leprae but not in animals sensitized with either the autoclaved M. leprae 
or other mycobacterial preparations. Antigens in other fractions - A,C,D 
and E exhibited cross-reactivity with other mycobacteria. Fraction A 
possessed antigens that cross-reacted with M. kansasii, M. avium and M. 
vaccae. Fraction C appeared to be present in all the mycobacteria studied. 
One of the antigens in this fraction could be the beta-antigen that has 
been shown by Navalkar (1977) and Norlin (1965) to be common to 
the majority of mycobacterial strains they studied. Both fractions D and 
E share antigenic determinants with intracellulare. Of particular 
interest were the antigens in fractions C,D, and E, that showed positive 
reactions in animals sensitized with autoclaved M. leprae, thus indicating 
that these antigens were heat-stable, and may possess immunogenic capabi¬ 
lities, since the heat-treated M_^ leprae has been shown to be highly 
immunogenic (Shepard et al., 1978; Graham and Navalkar, 1984). The 
antigens in fractions A and B did not elicit any reactions in the auto¬ 
claved M. leprae sensitized animals, indicating their heat-liability. 
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Experiments designed to assess the ability of the antigens to 
detect antibodies both in the homologous and heterologous systems, have 
indicated that except for one of the fractions, fraction B, each one has 
exhibited cross-reactivity, either across the whole spectrum of the re¬ 
ference system used or with some of the system. The fact that fraction 
B contains an antigen that showed strong reactions with anti- leprae 
antiserum and a rather weak raction with anti- M. tuberculosis antiserum, 
indicates that this antigen is a major primary component of the antigenic 
mosaic of M. leprae with perhaps a minor determinant shared with M. tuber¬ 
culosis. 
The footpad studies in mice have indicated that once the sensitization 
was induced it persisted throughout the experimental protocol, despite the 
quantity of protein and the aqueous state in which it was administered. 
It is likely that once the initial T-cell populations were primed, they 
continued to proliferate and thus allowed the retention of sensitivity. 
Perhaps, if the experimental protocols were to be extended, a gradual 
decline in sensitization might have been observed. In previous studies 
on cell-mediated immunity to M. leprae in mice (Navalkar, 1971), a situ¬ 
ation similar to the latter aspect was observed when mice sensitized 
with 5 x 1C)3 killed M. leprae exhibited a steady decline in skin reacti¬ 
vity, as opposed to mice infected with viable M. leprae. The decline was 
attributed to dimunition in the antigenic stimulus as time progressed. 
The early onset of skin reactivity in animals sensitized with the 
fractions indicates that the antigens in these fractions possess pro¬ 
perties of high level sensitization. Subsequent studies using the 
65 
fractions for both induction as well as elicitation, have confirmed the 
fact that the antigens do possess induction capabilities in addition to 
elicitation properties. In two studies the differences with regard to 
detection of skin reactivity over a prolonged period could be attributed 
to the fact that in the first experiment the whole cell sonicate was used 
as an elicitating agent. This could have assisted in permitting the 
detection of the actual state of sensitization induced in the animals. 
The lymphocyte transformation studies have shown that the antigen(s) 
in each fraction possess the ability to induce DNA synthesis, although 
this activity differs from fraction to fraction. In all instances, with 
regard to the fractions from untreated M. leprae, the blastogénie response 
is at a higher level in the first week after sensitization, which there¬ 
after decreases with time. The SI exhibited by fractions B,C and E was 
higher than the other two fractions, both in the beginning and at other 
intervals. However, the response to the antigens in fraction E declined 
totally at the time of termination of the experiments. This appears to 
parallel the skin reactivity studies for this fraction. Of the two 
remaining fractions, only fraction B appeared to retain a comparatively 
high and steady rate of activity, thus indicating its antigenic potency. 
The SI for fraction A and D is at a level lower than that of the other 
fractions. It is likely that the CM1 inducing properties of these anti¬ 
gens could be at a lower level than that of the other antigens. 
With the fractions from autoclaved M. leprae, fraction 1 appeared to 
possess a consistently high rate of activity, whereas the SI by all other 
fractions declined with time. The skin-reactivity studies with this 
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fraction indicate a similar phenomenon. Whether the antigens in this 
fraction also possess strong immunoprotective capabilities remains to be 
elucidated. Considering the fact that autoclaved M. leprae in general 
induce protection in mice infected with M. leprae (Graham and Navalkar, 
1984) it is likely that this fraction may have a major role to play in 
that phenomenon. 
SDS-PAGE analysis of the untreated M. leprae cell sonicate and the 
antigens present in these fractions were done to determine specifically 
whether fraction B, which showed a high degree of relatedness to M. 
leprae, possesses one or more antigens thus establishing its purity. The 
studies have clearly indicated that there is only one band present in 
that fraction with a molecular weight between 45,000 to 66,000, whereas 
the other fractions showed several bands. The whole cell sonicate of the 
untreated M. leprae showed a wide range of molecular weight distribution 
which range from 14,000 to above 94,000. These observations were similar 
to those of other workers who have used the SDS-PAGE analysis to determine 
the serological specificity and cross-reactivity of the various antigens 
of M. leprae (Chakrabarty et al_., 1982; Ivanyi et^^l_., 1983; and Klaster 
et_ aj_., 1984). However, it is recognized that further studies using sera 
from both leprosy and tuberculosis (typical and atypical) patients would 
be necessary to confirm the specificity of fraction B. Such M. leprae 
specific antigens could play a significant role in the immune response of 
patients. They could also be considered as possible immunodiagnostic as 
well as immuno-protective agents. 
CHAPTER VI 
SUMMARY 
1. The proteins of all mycobacterial strains tested by isoelectric- 
focusing were all acidic in nature. 
2. The proteins of M. leprae has a unique IEF pattern different from 
all other mycobacteria. 
3. All protein fractions were capable of both inducing as well as 
eliciting delayed skin-reactivity. 
4. Fraction B was highly specific for M. leprae by delayed hypersensi¬ 
tivity and recognition by antibody of immunized animals. 
5. This M. leprae-specific protein that we identified has the potential 
of being used.as a possible skin-test antigen for the early diagnosis 
of leprosy, specifically in contacts with leprosy patients, or in the 
preclinical stage of the disease. 
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APPENDIX 
Lower gel buffer (4 x): 
Tris 205.6g (Schwarz-Mann, Inc. Spring Valley, New York) are 
titrated with 2N HC1 to pH 9.18, add water to bring the final volume to 
1000 ml. 
Lower reservoir buffer: 
Lower gel buffer diluted 1:4 with water. 
Upper gel buffer (4X): 
Tris (2.62g) was titrated with 2M sulfuric acid to pH 6.14, and 
brought to added 100 ml with distilled water. 
Upper reservoir buffer (IX): 
Boric acid (2.47g) 4.92 g of Tris; 10 ml of 10% SDS in water, add 
water to!000 ml. 
Resolving gel (41% T and 2.44% C): 
Acrylamide monomers (41 g) 2.44 g of N,N'-methylene-bisacrylamide, 
add water to 100 ml and filter through 0.22 urn filter. 
Stacking gel, (4X) (3% T:0.3% C): 
Acrylamide (3.0g) 0.3 g of N,N'-methylene-bisacrylamide, add 
water to 25 ml and filter through 0.22 urn filter. 
Ammonium persulfate (AP): 
We used 6 mg/ml of (AP) in water. This solution is diluted 1:8 for 
stacking gel. 
N,N,N1,N1-Tetramethylenediamine (TEMED): 
We used 75 ul/ml of (TEMED) in water. This solution is diluted 1:4 
for stacking gel". 
Glycerol : 
We used 50% with a trace of bromophenol blue in water. 
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